000 01109nam a22003377a 4500
008 210628s20212021 xxu||||| |||| 00| 0 eng d
022 _a2078-6891
024 _a10.21037/jgo-2020-11 [doi]
024 _ajgo-12-S1-S57 [pii]
024 _aPMC8100712 [pmc]
040 _aOvid MEDLINE(R)
099 _a33970162
245 _aSuper-responders to bidirectional neoadjuvant chemotherapy showed prolonged survival.
251 _aJournal of Gastrointestinal Oncology. 12(Suppl 1):S57-S58, 2021 Apr.
252 _aJ. gastrointest. oncol.. 12(Suppl 1):S57-S58, 2021 Apr.
253 _aJournal of gastrointestinal oncology
260 _c2021
260 _fFY2021
260 _p2021 Apr
265 _sppublish
266 _d2021-06-28
546 _aEnglish
650 _aIN PROCESS -- NOT YET INDEXED
651 _aWashington Cancer Institute
657 _aComment
657 _aEditorial
700 _aSugarbaker, Paul H
790 _aSugarbaker PH, Van der Speeten K
856 _uhttps://dx.doi.org/10.21037/jgo-2020-11
_zhttps://dx.doi.org/10.21037/jgo-2020-11
942 _cART
_dArticle
999 _c6566
_d6566